Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression databases--resources for pharmacogenomic R&D.

L M Furness1, S Henrichwark, M Egerton

  • 1Incyte Genomics Ltd., Cambridge, UK. mfurness@incyte.com

Pharmacogenomics
|March 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.

Journal of neurochemistry·2006
Same author

Tryptophan metabolism and oxidative stress in patients with chronic brain injury.

European journal of neurology·2006
Same author

Tryptophan metabolism and oxidative stress in patients with Huntington's disease.

Journal of neurochemistry·2005
Same author

Tryptophan loading induces oxidative stress.

Free radical research·2004
Same author

Lessons to be learned: a case study approach. Unseasonal severe poisoning of two adults by deadly nightside (Atropa belladonna).

The journal of the Royal Society for the Promotion of Health·2000
Same author

The pharmacology of apoptosis.

Trends in pharmacological sciences·1999

Biological databases in genomics, pharmacogenomics, pharmacogenetics, and proteomics offer insights into fundamental biology and drug discovery. Integrating these datasets provides significant advantages for research and development.

Area of Science:

  • Molecular biology
  • Bioinformatics
  • Genomics
  • Pharmacogenomics
  • Pharmacogenetics
  • Proteomics

Background:

  • Advancements in biological research generate vast datasets.
  • Understanding fundamental biological processes is crucial.
  • Identifying novel drug targets requires comprehensive data analysis.

Purpose of the Study:

  • To review key biological databases.
  • To explore applications in drug target identification and compound profiling.
  • To highlight the benefits of integrating diverse biological datasets.

Main Methods:

  • Overview of genomics data and applications.
  • Review of pharmacogenomics and pharmacogenetics data.

Related Experiment Videos

  • Examination of proteomics data and its relevance.
  • Discussion on data integration strategies.

    • Main Results:

    • Individual datasets offer valuable insights.
    • Integration of genomics, pharmacogenomics, pharmacogenetics, and proteomics data unlocks synergistic advantages.
    • Enhanced compound profiling and drug target identification are potential outcomes.

    Conclusions:

    • Biological databases are essential tools for modern research.
    • Integrating diverse data types significantly amplifies research potential.
    • Future research should focus on comprehensive data integration for accelerated discovery.